| Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma (NCT05362409) | Alpheus Medical, Inc. | 2022-06-29 |
| A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors (NCT04865315) | Maastricht Radiation Oncology | 2022-05-01 |
| The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) (NCT06118723) | Jasper Gerritsen | 2022-01-01 |
| A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) (NCT04573140) | University of Florida | 2021-12-13 |
| Study of DSP-0390 in Patients With Recurrent High-Grade Glioma (NCT05023551) | Sumitomo Pharma America, Inc. | 2021-09-08 |
| SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue (NCT04734444) | SonoClear AS | 2021-09-01 |
| NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma (NCT04851834) | Xennials Therapeutics Australia Pty Ltd | 2021-08-25 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
| Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas (NCT04766632) | Central Hospital, Nancy, France | 2021-05-18 |
| A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion (NCT04655404) | Nationwide Children's Hospital | 2021-04-08 |
| Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma (NCT04559685) | Nader Sanai | 2021-03-15 |
| Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection (NCT04608812) | OncoSynergy, Inc. | 2021-03-02 |
| Seizures During Radiotherapy for High-grade Gliomas (NCT04552756) | University Hospital Schleswig-Holstein | 2021-03-01 |
| BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels (NCT05375318) | Juan M Garcia-Gomez | 2021-03-01 |
| Glioma Supra Marginal Incision Trial (NCT04737577) | Sunnybrook Health Sciences Centre | 2021-02-05 |
| Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors (NCT04299191) | Laminar Pharmaceuticals | 2020-09-01 |
| Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma (NCT04220892) | Jose Carrillo | 2020-07-08 |
| Neoadjuvant Chemoradiation for Resectable Glioblastoma (NCT04209790) | Geisinger Clinic | 2020-04-01 |
| Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas (NCT03971734) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-06 |
| Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy (NCT03952598) | National Cancer Institute (NCI) | 2019-10-16 |
| Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas (NCT03925246) | Assistance Publique - Hôpitaux de Paris | 2019-07-30 |
| Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (NCT03973918) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-29 |
| Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma (NCT04267146) | Gustave Roussy, Cancer Campus, Grand Paris | 2019-07-15 |
| Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype (NCT03718767) | National Cancer Institute (NCI) | 2019-03-27 |
| Glioma and Exercising (NCT03775369) | University Hospital, Basel, Switzerland | 2018-10-26 |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 (NCT02655601) | BioMimetix JV, LLC | 2018-09-25 |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma (NCT03690869) | Regeneron Pharmaceuticals | 2018-09-24 |
| Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas (NCT03334305) | University of Florida | 2018-08-27 |
| A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma (NCT03605550) | Nationwide Children's Hospital | 2018-08-01 |
| Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery (NCT05873946) | Hospital del Rio Hortega | 2018-06-01 |
| Nurse-led Family and Network Consultations (NCT03458312) | Rigshospitalet, Denmark | 2018-04-09 |
| Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) (NCT03392545) | Beijing Tiantan Hospital | 2018-04-01 |
| Dabrafenib and/or Trametinib Rollover Study (NCT03340506) | Novartis Pharmaceuticals | 2018-01-26 |
| Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations (NCT03352427) | University of Michigan Rogel Cancer Center | 2017-12-06 |
| A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) (NCT03355794) | Children's Hospital Medical Center, Cincinnati | 2017-11-14 |
| Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas (NCT02970448) | Case Comprehensive Cancer Center | 2017-08-24 |
| Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children (NCT02885324) | Indiana University | 2017-05-18 |
| HUMC 1612: Optune NovoTTF-200A System (NCT03128047) | Hackensack Meridian Health | 2017-04-06 |
| Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) (NCT03294434) | CCTU- Cancer Theme | 2017-03-02 |
| Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma (NCT02848794) | The First People's Hospital of Lianyungang | 2016-07-01 |
| Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection (NCT02500459) | Michael Vogelbaum, MD, PhD | 2015-07-06 |
| HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) (NCT02239952) | Amsterdam UMC, location VUmc | 2014-11-01 |
| Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma (NCT02022644) | University of California, San Francisco | 2014-10-23 |
| Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC) (NCT02305056) | University Hospital, Grenoble | 2014-09-01 |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors (NCT01902771) | Edward Ziga | 2013-09-03 |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma (NCT01808820) | Macarena De La Fuente, MD | 2013-08-21 |
| Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG) (NCT01644773) | St. Jude Children's Research Hospital | 2012-11-27 |
| Low Dose Radiation Therapy for Glioblastoma Multiforme (NCT01466686) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
| Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas (NCT02041611) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-07-13 |
| Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma (NCT01499823) | Seoul National University Hospital | 2011-12-01 |
| A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma (NCT01390948) | Hoffmann-La Roche | 2011-10-18 |
| Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab (NCT01403610) | The University of Texas Health Science Center at San Antonio | 2011-06-01 |
| Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas (NCT01222754) | National Cancer Institute (NCI) | 2010-11-23 |
| Radiation Planning Study for High Grade Brain Tumors (NCT01191346) | University of Cincinnati | 2010-06-01 |
| Personalized Translational Platform for Biomarker Discovery in Brain Tumors (NCT01240161) | Marcelo F. Di Carli, MD, FACC | 2009-12-01 |
| Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma (NCT00826930) | Diffusion Pharmaceuticals Inc | 2009-03-01 |
| Borderzone Sampling (NCT00780819) | Maastricht University Medical Center | 2008-10-01 |
| Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) (NCT00624728) | University Hospital, Bordeaux | 2008-02-01 |
| Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM (NCT00548938) | Methodist Healthcare - Memphis | 2007-10-01 |
| Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma (NCT00589875) | Candel Therapeutics, Inc. | 2007-03-01 |
| Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma (NCT00897611) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-04-01 |
| Nimotuzumab in Children With HGG (NCT00561873) | Oncoscience AG | 2004-06-01 |
| Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma (NCT00003535) | Burzynski Research Institute | 1994-04-01 |
| Individual Patient Compassionate Use of GX-I7 (NCT04289155) | Genexine, Inc. | |